Plaintiff

Zimmer Biomet

1 case as plaintiff.

Cases
1
Active
1
0 closed
Filed
2019
Top venue
D Del
1 case

Company profile

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), commonly "Zimmer Biomet," is a publicly traded American medical-device manufacturer headquartered at 345 East Main Street, Warsaw, Indiana. The company traces its history to 1927, when Justin O. Zimmer founded Zimmer Manufacturing Company in Warsaw; the current Delaware-incorporated parent was spun off from its former parent in 2001 and took its present name after acquiring Biomet in 2015. It is an operating company, not a holding/NPE vehicle. Press and financial profiles put headcount at roughly 17,000 employees and FY2025 net sales at about $8.23 billion (FY2024: $7.68 billion).

Products / operations. Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants and related technologies. Its portfolio spans knee, hip, and shoulder reconstruction (e.g., Persona, NexGen, Vanguard, and Gender Solutions knee systems); sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; bone cement and surgical products; and integrated digital and robotic technologies, including its Signature Personalized Patient Care patient-specific instrumentation. It sells through direct channels and distributors across three regional segments: Americas; EMEA; and Asia Pacific. Its main customers are orthopedic surgeons, neurosurgeons, hospitals, and buying groups.

Patent-litigation posture. The tracked data show Zimmer Biomet on the plaintiff side in a single case (Zimmer US, Inc. et al. v. Conformis, Inc., filed 2019-11-05 in D. Del.) and zero cases as a defendant. That one-off plaintiff appearance reflects a defensive/declaratory response in an active dispute rather than an NPE-style assertion campaign; the company is an operating manufacturer, not a patent-assertion entity. The matter sits in the District of Delaware, a common venue for medical-device patent suits.

Context. External sources show Conformis, Inc. (Billerica, Mass.) sued Zimmer Biomet in D. Del. in August 2019 over patient-specific knee, hip, and shoulder instrumentation patents, alleging infringement by Zimmer's Signature, Persona, NexGen, Vanguard, and Gender Solutions systems. The parties settled in May 2020, dismissing all litigation, cross-licensing their respective patient-specific instrument and implant patents, with Zimmer paying Conformis $9.6 million.

Keep this research.

Save to your free workspace, then choose whether to receive updates.

Zimmer US, Inc. et al. v. Conformis, Inc.

pending
Docket:
1:19-cv-02093
Court:
D. Del.
Filed:
2019-11-05
Patents:8556983

Zimmer US and Zimmer Biomet filed a declaratory-judgment action against Conformis in the District of Delaware. The case was pending per the last docket update. Narrative states the '983 patent was not identified as asserted in this case.